Circassia Pharmaceuticals appoints Jonathan Emms as chief operating officer

07:29 12/08/2019 - Circassia Pharmaceuticals appointed Jonathan Emms to the newly-created role of chief operating officer.

As COO, Emms would further strengthen Circassia's commercial focus and lead the company's global commercial strategy and operational management. He would also join the company's board as an executive director when he joins Circassia on 2 September 2019.

At the same time Circassia's Senior Vice President of R&D, Dr Rod Hafner, would step down from the Board after 11 years as a director, reflecting the company's commercial focus and the approval process for Duaklir and Tudorza's sNDA. He would remain a key member of Circassia's Senior Management Team, however, and continue in his role leading the company's business development, supply chain, medical affairs, regulatory and quality activities.

Jonathan Emms, an established commercial leader, who brought significant senior-level experience of the global pharmaceutical industry to Circassia, the company said. Prior to joining the company, he was chief commercial officer for Pfizer's internal medicines organisation, where he led commercial activities across the company's global operations.

Story provided by



What the Papers Say

telegraph financial times daily mail daily express independent times
21:39 FirstFT: Today’s top stories 
21:33 PG&E sinks to 7-month low on new wildfire...
21:30 Wall Street rises for third day while...
20:09 China social media accounts suspended over...
19:48 Banking bodies look at shorter trading day...
19:47 Hong Kong billionaire to buy pub group...
19:46 Royal Mail accord with workers is...
19:45 Markets rally despite new Germany...
source: The Guardian
19:20 Saxo chief predicts more fintech takeovers
19:16 Auction blunder sees sale of oldest...
source: The Daily Mail
[more ...]